1 Death of baby (up to discharge) |
9 |
931 |
Risk Ratio (M‐H, Random, 95% CI) |
0.81 [0.47, 1.41] |
1.1 < 32‐34 weeks gestation |
8 |
731 |
Risk Ratio (M‐H, Random, 95% CI) |
0.70 [0.38, 1.29] |
1.2 > 32‐34 weeks gestation |
1 |
200 |
Risk Ratio (M‐H, Random, 95% CI) |
1.5 [0.44, 5.15] |
1.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2 Death or neurodevelopmental impairment at age two to three years |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3 Severe intraventricular haemorrhage (IVH grades 3, 4) |
6 |
618 |
Risk Ratio (M‐H, Random, 95% CI) |
0.75 [0.39, 1.45] |
3.1 < 32‐34 weeks gestation |
6 |
618 |
Risk Ratio (M‐H, Random, 95% CI) |
0.75 [0.39, 1.45] |
3.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4 Intraventricular haemorrhage (IVH, all grades) |
8 |
716 |
Risk Ratio (M‐H, Random, 95% CI) |
0.85 [0.62, 1.18] |
4.1 < 32‐34 weeks gestation |
8 |
716 |
Risk Ratio (M‐H, Random, 95% CI) |
0.85 [0.62, 1.18] |
4.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5 Periventricular leukomalacia (PVL) |
3 |
315 |
Risk Ratio (M‐H, Random, 95% CI) |
0.63 [0.15, 2.63] |
5.1 < 32‐34 weeks gestation |
3 |
315 |
Risk Ratio (M‐H, Random, 95% CI) |
0.63 [0.15, 2.63] |
5.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6 Chronic lung disease (CLD) ‐ oxygen supplement at 36 weeks (corrected for gestation) |
7 |
682 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.64, 1.66] |
6.1 < 32‐34 weeks gestation |
7 |
682 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.64, 1.66] |
6.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7 Maternal blood loss of 500 mL or greater |
1 |
200 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.1 < 32‐34 weeks gestation |
1 |
200 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
8 Intraventricular haemorrhage (IVH, grades 1 & 2) |
6 |
618 |
Risk Ratio (M‐H, Random, 95% CI) |
0.74 [0.44, 1.25] |
8.1 < 32‐34 weeks gestation |
6 |
618 |
Risk Ratio (M‐H, Random, 95% CI) |
0.74 [0.44, 1.25] |
8.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
8.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
9 Necrotising enterocolitis (NEC) confirmed by X‐ray or laparotomy) |
6 |
616 |
Risk Ratio (M‐H, Random, 95% CI) |
0.75 [0.41, 1.38] |
9.1 < 32‐34 weeks gestation |
6 |
616 |
Risk Ratio (M‐H, Random, 95% CI) |
0.75 [0.41, 1.38] |
9.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
9.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
10 Respiratory Distress Syndrome (RDS) |
4 |
515 |
Risk Ratio (M‐H, Random, 95% CI) |
1.05 [0.83, 1.32] |
10.1 < 32‐34 weeks gestation |
3 |
315 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.95, 1.05] |
10.2 > 32‐34 weeks gestation |
1 |
200 |
Risk Ratio (M‐H, Random, 95% CI) |
2.0 [0.71, 5.64] |
10.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
11 Respiratory support (ventilator or CPAP) |
2 |
129 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [0.74, 1.47] |
11.1 < 32‐34 weeks gestation |
2 |
129 |
Risk Ratio (M‐H, Random, 95% CI) |
1.04 [0.74, 1.47] |
11.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
11.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
12 Duration of respiratory support (days) |
1 |
199 |
Mean Difference (IV, Random, 95% CI) |
2.80 [‐9.78, 15.38] |
12.1 < 32‐34 weeks gestation |
1 |
199 |
Mean Difference (IV, Random, 95% CI) |
2.80 [‐9.78, 15.38] |
12.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
12.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
13 Surfactant treatment (for severe RDS) |
5 |
433 |
Risk Ratio (M‐H, Random, 95% CI) |
1.13 [0.81, 1.58] |
13.1 < 32‐34 weeks gestation |
5 |
433 |
Risk Ratio (M‐H, Random, 95% CI) |
1.13 [0.81, 1.58] |
13.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
13.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
14 Treatment for Patent Ductus Arteriosus (PDA) (medical and/or surgical) |
5 |
411 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.73, 1.38] |
14.1 < 32‐34 weeks gestation |
5 |
411 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.73, 1.38] |
14.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
14.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
15 Treatment for Retinopathy of Prematurity (RoP) |
5 |
274 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.76, 1.19] |
15.1 < 32‐34 weeks gestation |
5 |
274 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.76, 1.19] |
15.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
15.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
16 Hyperbilirubinemia (treated by phototherapy) |
3 |
475 |
Risk Ratio (M‐H, Random, 95% CI) |
1.39 [0.73, 2.63] |
16.1 < 32‐34 weeks gestation |
2 |
275 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.86, 1.06] |
16.2 > 32‐34 weeks gestation |
1 |
200 |
Risk Ratio (M‐H, Random, 95% CI) |
3.67 [1.85, 7.26] |
16.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
17 Inotropics for low blood pressure |
3 |
300 |
Risk Ratio (M‐H, Random, 95% CI) |
0.61 [0.36, 1.04] |
17.1 < 32‐34 weeks gestation |
3 |
300 |
Risk Ratio (M‐H, Random, 95% CI) |
0.61 [0.36, 1.04] |
17.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
17.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18 Low Apgar as defined by trialists (generally < 8 at 5 mins) |
2 |
398 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.67, 1.60] |
18.1 < 32‐34 weeks gestation |
2 |
398 |
Risk Ratio (M‐H, Random, 95% CI) |
1.03 [0.67, 1.60] |
18.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
19 Blood transfusion in infant |
6 |
567 |
Risk Ratio (M‐H, Random, 95% CI) |
0.71 [0.57, 0.89] |
19.1 < 32‐34 weeks gestation |
6 |
567 |
Risk Ratio (M‐H, Random, 95% CI) |
0.71 [0.57, 0.89] |
19.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
19.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
20 Volume of blood transfused (mL) |
1 |
199 |
Mean Difference (IV, Random, 95% CI) |
‐19.0 [‐39.61, 1.61] |
20.1 < 32‐34 weeks gestation |
1 |
199 |
Mean Difference (IV, Random, 95% CI) |
‐19.0 [‐39.61, 1.61] |
20.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
21 Late sepsis (after 3 days or as defined by trialists) |
4 |
385 |
Risk Ratio (M‐H, Random, 95% CI) |
0.87 [0.64, 1.19] |
21.1 < 32‐34 weeks gestation |
4 |
385 |
Risk Ratio (M‐H, Random, 95% CI) |
0.87 [0.64, 1.19] |
21.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
21.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
22 Hydrocephalus |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
22.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
22.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
22.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23 Temperature < 36.0oC within 1 hour of birth |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
24 Hb within 1st 24 hour of birth (g/dL) |
7 |
905 |
Mean Difference (IV, Random, 95% CI) |
0.84 [0.54, 1.14] |
24.1 < 32‐34 weeks gestation |
6 |
705 |
Mean Difference (IV, Random, 95% CI) |
0.87 [0.54, 1.20] |
24.2 > 32‐34 weeks gestation |
1 |
200 |
Mean Difference (IV, Random, 95% CI) |
0.70 [0.00, 1.40] |
24.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
25 Mean arterial blood pressure |
2 |
408 |
Mean Difference (IV, Random, 95% CI) |
0.38 [‐1.33, 2.09] |
25.1 < 32‐34 weeks gestation |
1 |
208 |
Mean Difference (IV, Random, 95% CI) |
0.0 [‐2.17, 2.17] |
25.2 > 32‐34 weeks gestation |
1 |
200 |
Mean Difference (IV, Random, 95% CI) |
1.0 [‐1.76, 3.76] |
25.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26 Length of infant stay in NICU (in weeks) |
1 |
199 |
Mean Difference (IV, Random, 95% CI) |
5.30 [‐5.49, 16.09] |
26.1 < 32‐34 weeks gestation |
1 |
199 |
Mean Difference (IV, Random, 95% CI) |
5.30 [‐5.49, 16.09] |
26.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
27 Home oxygen |
1 |
199 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.38, 2.10] |
27.1 < 32‐34 weeks gestation |
1 |
199 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.38, 2.10] |
27.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
27.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
28 Neurodevelopmental impairment at age two to three years |
2 |
187 |
Risk Ratio (M‐H, Random, 95% CI) |
1.25 [0.49, 3.17] |
28.1 < 32‐34 weeks gestation |
2 |
187 |
Risk Ratio (M‐H, Random, 95% CI) |
1.25 [0.49, 3.17] |
28.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
28.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29 Severe visual impairment |
1 |
125 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29.1 < 32‐34 weeks gestation |
1 |
125 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30 Cerebral palsy (CP) |
2 |
286 |
Risk Ratio (M‐H, Random, 95% CI) |
0.70 [0.05, 10.63] |
30.1 < 32‐34 weeks gestation |
2 |
286 |
Risk Ratio (M‐H, Random, 95% CI) |
0.70 [0.05, 10.63] |
30.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31 Manual removal of placenta (denominator = vaginal births) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32 Prolonged third stage (> 30 minutes) (denominator = vaginal births) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
33 Blood transfusion for mother |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
33.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
33.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
33.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34 Postpartum infection in mother |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35 Rhesus isoimmunisation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
36 Psychological well being in mother |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
36.1 < 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
36.2 > 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
36.3 Mixed gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37 Bonding |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37.1 < 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37.2 > 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37.3 Mixed gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
38 Breastfeeding initiation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
38.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
38.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
38.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
39 Fully breastfed or mixed feeding at infant discharge |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
39.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
39.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
39.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40 Maternal anxiety |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
41 Mothers' views |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
41.1 < 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
41.2 > 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
41.3 Mixed gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |